J. David Barrans

J. David Barrans

Osler, Hoskin & Harcourt LLP

Contact  |  View Bio  |  RSS

Latest Publications

Share:

The U.S. Supreme Court’s Decision in Myriad Genetics Sets Higher Patentability Requirements than in Canada

In a recent decision that could significantly affect the biotechnology industry, the United States Supreme Court in Association for Molecular Pathology v. Myriad Genetics, Inc., No. 12-398 (June 13, 2013), held that “a...more

6/27/2013 - AMP v Myriad Canada DNA Human Genes Myriad Patent-Eligible Subject Matter Patents SCOTUS

1 Results
|
View per page
Page: of 1